GlassScriptPhysician profile
Madhavi A Reddy
NPI 1588667471
$1,219.57
in general payments reported to CMS, 2019-2025
20 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $13.15 · 2021: $272 · 2022: $79.40 · 2023: $222 · 2024: $228 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $158.73 | 2019-2025 | |
| Stryker Corporation | $153.02 | 2023-2024 | Infinity Adaptis, Prophecy |
| Astellas Pharma US INC | $145.87 | 2021-2024 | Veozah |
| Gilead Sciences, INC. | $119.22 | 2019 | |
| Glaxosmithkline, LLC. | $107.21 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $80.23 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Inspire Medical Systems, INC. | $68.41 | 2023-2025 | Inspire |
| Biosense Webster, INC. | $64.52 | 2021 | |
| Dexcom, INC. | $58.46 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $43.31 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $32.47 | 2021 | |
| Phathom Pharmaceuticals, INC. | $27.10 | 2024 | Voquezna |
| Acclarent, INC | $24.04 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.00 | 2023 | Rexulti |
| Edwards Lifesciences Corporation | $22.03 | 2025 | Sapien 3 Ultra Resilia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.89 | 2022 | |
| Xeris Pharmaceuticals, INC. | $21.40 | 2022 | |
| Procept Biorobotics Corporation | $19.18 | 2024 | Aquabeam System |
| Bausch Health US, LLC | $15.52 | 2025 | Aplenzin |
| Mayne Pharma Commercial LLC | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madhavi Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.